SunAct | Advanced Cancer Therapies

SunAct is a pioneer in Advanced Cancer Therapies, committed to redefining the future of oncology care in India. With a focus on innovative Cell and Gene Therapies (CGT)—including CAR T - cell therapies, TCR, TIL, Gamma Delta therapies, Gene Therapy, and Stem Cell Transplants. SunAct proudly stands as the first organization to introduce these cutting-edge therapeutic modalities to cancer patients across the nation. The organization’s mission is clear: to ensure that the promise of advanced cancer care is both accessible and affordable for India’s vast underserved population. At the heart of SunAct are its visionary founders, Dr. Vijay Patil and Dr. Ashay Karpe. Recognized as leaders in the fields of oncology and CGT, their expertise and passion have powered the organization’s relentless pursuit of innovative cancer care. Their clinical insights, honed by years of experience, have not only shaped a pioneering treatment model but have also guided strategic initiatives that continue to push the boundaries of conventional oncology. Every initiative at SunAct is underscored by an unwavering belief in the transformative power of advanced therapeutics. The organization understands that innovation in cancer treatment is not merely about deploying new technologies but also about instilling hope and improving quality of life. With each therapy, clinical trial, and partnership, SunAct strives to turn a progressive vision into a living reality—a reality where every patient has the opportunity to achieve better outcomes and a brighter future.